Mustang Bio, Inc. SEC filings MBIO

Mustang Bio, Inc. has 405 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.

Mustang Bio, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 5, 2026 —
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 15, 2026 Oct 13, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
4 Insider transaction Apr 27, 2026 Apr 24, 2026
8-K Current report
Listing notice
Apr 17, 2026 Apr 15, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 30, 2025 Dec 30, 2025
8-K Current report
Shareholder vote results, Other events
Dec 23, 2025 Dec 17, 2025
DEF 14A Proxy statement Dec 3, 2025 Dec 22, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 1, 2025 —
4 Insider transaction Oct 1, 2025 Sep 29, 2025
424B5 Prospectus supplement Sep 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
4 Insider transaction Apr 28, 2025 Apr 24, 2025
EFFECT Filing Apr 11, 2025 —
POS AM Filing Apr 4, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
POS EX Filing Apr 1, 2025 —
424B3 Prospectus Apr 1, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 5, 2025 Mar 5, 2025
DEF 14C Information statement Mar 3, 2025 Mar 3, 2025
424B3 Prospectus Feb 27, 2025 —
8-K Current report
Acquisition or sale of assets, Other events
Feb 27, 2025 Feb 21, 2025
PRE 14C Filing Feb 21, 2025 Feb 21, 2025
8-K Current report
Shareholder vote results
Feb 21, 2025 Feb 19, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
424B3 Prospectus Feb 13, 2025 —
8-K Current report
Material agreement, Agreement ended
Feb 13, 2025 Feb 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2025 —
8-K Current report
Material agreement, Other events
Feb 11, 2025 Feb 5, 2025
424B4 Prospectus Feb 7, 2025 —
EFFECT Filing Feb 5, 2025 —
CORRESP Letter to the SEC Feb 5, 2025 —
S-1/A Amended registration statement Feb 5, 2025 —
DEF 14C Information statement Jan 22, 2025 Jan 22, 2025
UPLOAD Letter from the SEC Jan 20, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jan 17, 2025 Jan 14, 2025
S-1 Registration statement Jan 15, 2025 —
PRE 14C Filing Jan 10, 2025 Jan 10, 2025
8-K Current report
Shareholder vote results
Jan 10, 2025 Jan 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
3 Initial insider ownership Jan 3, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
Jan 2, 2025 Dec 26, 2024
DEF 14A Proxy statement Dec 6, 2024 Dec 26, 2024
424B3 Prospectus Dec 2, 2024 —
EFFECT Filing Nov 27, 2024 —
CORRESP Letter to the SEC Nov 25, 2024 —
UPLOAD Letter from the SEC Nov 25, 2024 —
S-3 Shelf registration Nov 22, 2024 —
8-K Current report
Listing notice, Officer or director change
Nov 15, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Other events
Nov 6, 2024 Nov 6, 2024
3 Initial insider ownership Oct 29, 2024 Oct 23, 2024
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Oct 25, 2024 Oct 23, 2024
8-K Current report
Listing notice
Sep 13, 2024 Sep 10, 2024
424B5 Prospectus supplement Aug 16, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
EFFECT Filing Jul 29, 2024 —
CORRESP Letter to the SEC Jul 25, 2024 —
UPLOAD Letter from the SEC Jul 25, 2024 —
S-1 Registration statement Jul 19, 2024 —
DEF 14C Information statement Jul 10, 2024 Jul 10, 2024
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Shareholder vote results
Jul 3, 2024 Jun 27, 2024
424B5 Prospectus supplement Jul 3, 2024 —
PRE 14C Filing Jun 28, 2024 Jun 28, 2024
SC 13D/A Amended ownership over 5% (active) Jun 28, 2024 —
4 Insider transaction Jun 28, 2024 Jun 27, 2024
D Filing Jun 24, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 24, 2024 Jun 19, 2024
424B5 Prospectus supplement Jun 21, 2024 —
424B5 Prospectus supplement Jun 20, 2024 —
EFFECT Filing Jun 12, 2024 —
CORRESP Letter to the SEC Jun 10, 2024 —
8-K Current report
Material agreement, Agreement ended
Jun 6, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 Apr 24, 2022
UPLOAD Letter from the SEC Jun 4, 2024 —
S-3 Shelf registration May 31, 2024 —
8-K Current report
Listing notice, Other events
May 21, 2024 May 16, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
424B3 Prospectus May 13, 2024 —
8-K Current report
Material agreement, Other events
May 2, 2024 Apr 29, 2024
424B4 Prospectus May 1, 2024 —
EFFECT Filing Apr 29, 2024 —
EFFECT Filing Apr 29, 2024 —
CORRESP Letter to the SEC Apr 29, 2024 —
S-1/A Amended registration statement Apr 29, 2024 —
S-1/A Amended registration statement Apr 29, 2024 —
8-K Current report
Results of operations
Apr 29, 2024 Apr 29, 2024
CORRESP Letter to the SEC Apr 29, 2024 —
CORRESP Letter to the SEC Apr 29, 2024 —
S-1/A Amended registration statement Apr 29, 2024 —
8-K Current report
Exit or restructuring costs
Apr 12, 2024 Apr 10, 2024
S-1/A Amended registration statement Apr 2, 2024 —
8-K Current report
Other events
Mar 29, 2024 Mar 28, 2024
UPLOAD Letter from the SEC Mar 20, 2024 —
S-1 Registration statement Mar 15, 2024 —
8-K Current report
Listing notice
Mar 15, 2024 Mar 13, 2024
8-K Current report
Results of operations
Mar 11, 2024 Mar 11, 2024
10-K Annual report Mar 11, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 14, 2024 Feb 12, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
3 Initial insider ownership Feb 12, 2024 Jan 19, 2024
8-K Current report
Officer or director change
Jan 25, 2024 Jan 19, 2024
8-K Current report
Other events
Jan 4, 2024 Dec 28, 2023
4 Insider transaction Jan 3, 2024 Jan 2, 2024
3 Initial insider ownership Dec 19, 2023 Dec 11, 2023
UPLOAD Letter from the SEC Dec 18, 2023 —
S-1 Registration statement Dec 12, 2023 —
8-K Current report
Officer or director change
Dec 12, 2023 Dec 11, 2023
8-K Current report
Other events
Dec 11, 2023 Dec 11, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
D Filing Nov 3, 2023 —
8-K Current report
Other events
Nov 2, 2023 Nov 2, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 30, 2023 Oct 26, 2023
424B5 Prospectus supplement Oct 30, 2023 —
8-K Current report
Other events
Oct 26, 2023 Oct 26, 2023
8-K Current report
Other events
Oct 4, 2023 Sep 28, 2023
UPLOAD Letter from the SEC Sep 6, 2023 —
CORRESP Letter to the SEC Aug 28, 2023 —
UPLOAD Letter from the SEC Aug 23, 2023 —
8-K Current report
Other events
Aug 16, 2023 Aug 16, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
S-8 Employee stock plan registration Aug 1, 2023 —
8-K Current report
Material agreement, Acquisition or sale of assets
Jul 31, 2023 Jul 28, 2023
8-K Current report
Material agreement
Jul 20, 2023 Jul 18, 2023
8-K Current report
Agreement ended
Jul 11, 2023 Jul 10, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Apr 24, 2023
8-K Current report
Material agreement
Jun 30, 2023 Jun 29, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2023 Jun 21, 2023
8-K Current report
Material agreement, Agreement ended, Exit or restructuring costs, Other events
May 22, 2023 May 17, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 21, 2023
8-K Current report
Other events
Apr 20, 2023 Apr 14, 2023
424B5 Prospectus supplement Apr 14, 2023 —
8-K Current report
Agreement ended
Apr 13, 2023 Apr 11, 2023
3/A Ownership document Apr 6, 2023 Sep 26, 2016
3/A Ownership document Apr 6, 2023 Sep 26, 2016
4 Insider transaction Apr 3, 2023 Mar 18, 2022
4 Insider transaction Apr 3, 2023 Mar 18, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 3, 2023 Mar 28, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 29, 2023 Mar 29, 2023
DEF 14C Information statement Mar 13, 2023 Mar 13, 2023
PRE 14C Filing Mar 3, 2023 Mar 3, 2023
8-K Current report
Shareholder vote results
Mar 3, 2023 Mar 3, 2023
SC 13D/A Amended ownership over 5% (active) Jan 13, 2023 —
4 Insider transaction Jan 6, 2023 Jan 6, 2023
8-K Current report
Material agreement
Dec 13, 2022 Dec 7, 2022
8-K Current report
Other events
Nov 25, 2022 Nov 18, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
S-8 Employee stock plan registration Jul 15, 2022 —
SC 13G Ownership over 5% (passive) Jul 8, 2022 —
8-K Current report
Bylaw or fiscal year change
Jul 7, 2022 Jul 6, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2022 Jun 21, 2022
3 Initial insider ownership Jun 7, 2022 Apr 18, 2022
8-K Current report
Listing notice
May 31, 2022 May 24, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 21, 2022
8-K Current report
Officer or director change
Apr 22, 2022 Apr 18, 2022
PRE 14A Preliminary proxy statement Apr 19, 2022 Jun 21, 2022
8-K Current report
Results of operations
Mar 23, 2022 Mar 23, 2022
10-K Annual report Mar 23, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Mar 17, 2022 Mar 11, 2022
8-K Current report
Material agreement
Mar 8, 2022 Mar 4, 2022
SC 13G Ownership over 5% (passive) Feb 4, 2022 —
4 Insider transaction Dec 16, 2021 Dec 8, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1680048

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.